Oct 4, 2022
Arvinder Dhalla, VP of Clinical Development for Rani Therapeutics. Arvinder is a problem-solver, results-oriented, innovative scientist and leader with more than 20 years of Biotech and Med-tech experience in cardiovascular, endocrinology and PAH therapeutic areas. She led multiple drug development programs from early discovery to clinical development and participated in investigational new drug (IND) and new drug (NDA) applications which resulted in two drug approvals.
Here are some key moments from our conversation: